Silencing March1 reversed the tumor suppressive role of ciRs-6 on bladder cancer cells, which resulted in improved cell viability (Figure 6B, 6C), higher clone formation ability (Figure 6D–6F) and a higher percentage of cells in S phase (Figure 6G–6I). This evidence concerns the gene MARCHF1 and urinary bladder carcinoma.